| May 10 | May 09 | May 08 | |
|---|---|---|---|
| Income Statement | |||
| Total Revenue | |||
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -29.76K | $ -25.47K | $ -31.43K |
| EBITDA | $ -29.76K | $ -25.47K | $ -31.43K |
| Net Income | $ -34.76K | $ -25.47K | $ -31.43K |
| Balance Sheet | |||
| Cash & Short-Term Investments | $ ― | $ ― | $ ― |
| Total Assets | $ 2.48K | $ 18.69K | $ 15.27K |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -2.48K | $ -13.69K | $ -10.27K |
| Total Liabilities | $ 25.13K | $ 18.58K | $ 1.68K |
| Stockholders' Equity | $ ― | $ ― | $ ― |
| Cash Flow | |||
| Free Cash Flow | $ -12.71K | $ -14.57K | $ -18.34K |
| Operating Cash Flow | $ -12.71K | $ -14.57K | $ -18.34K |
| Investing Cash Flow | |||
| Financing Cash Flow |
Yutudao Marine Biotechnology Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.